title: Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.
abstract: The interferon regulatory factor-1 (IRF1) gene, localized on chromosome 5q31.1, is mutated or rearranged in several cancers including some hematopoietic and gastric cancers. However, whether loss of IRF1 occurs in sporadic breast cancer is unknown. Loss of 5q12-31 is reported in 11% of sporadic breast cancers, and high-resolution array-CGH studies have shown loss at 5q31.1 in 50% of breast cancers with a mutated BRCA1 gene. Functionally, overexpression of IRF1 reduces, and a dominant negative IRF1 construct increases, tumorigenesis of human breast cancer xenografts. Taken together, these observations indicate that the IRF1 gene may play a potentially important role as a breast cancer tumor suppressor gene. In this study, we investigated allelic loss of the IRF1 gene in breast tumor specimens from 52 women with invasive breast cancer using an IRF1 intragenic dinucleotide polymorphic marker. Thirty-seven cases were informative. LOH at the IRF1 locus was detected in 32% of these informative cases (12/37). There was a significant association between IRF1 loss and both older age (P = 0.0167) and earlier stage (Stages 1 and 2) (P = 0.0165). To assess the association of IRF1 mRNA expression with clinical outcomes in breast cancer, we studied data from two published gene expression microarray datasets. In breast cancer patients, low IRF1 mRNA expression is strongly correlated with both risk of recurrence (OR = 3.00; P = 0.003; n = 273 cases) and risk of death (OR = 4.18; P = 0.004; n = 191 cases). Our findings strongly imply a tumor suppressor role for the IRF1 gene in breast cancer.
authors.affiliation: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC 20057, USA.
authors.forename: Luciane R
authors.initials: LR
authors.lastname: Cavalli
authors.forename: Rebecca B
authors.initials: RB
authors.lastname: Riggins
authors.forename: Antai
authors.initials: A
authors.lastname: Wang
authors.forename: Robert
authors.initials: R
authors.lastname: Clarke
authors.forename: Bassem R
authors.initials: BR
authors.lastname: Haddad
mesh_terms: D000367:Age Factors; D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D005260:Female; D006801:Humans; D050856:Interferon Regulatory Factor-1 / Q000235:genetics*; D019656:Loss of Heterozygosity; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D014408:Biomarkers, Tumor; D050856:Interferon Regulatory Factor-1; D012333:RNA, Messenger
references.citation: Cancer Res. 2004 Jun 1;64(11):4030-9
references.pmid: 15173018
references.citation: Cancer. 2003 Jan 1;97(1):134-47
references.pmid: 12491515
references.citation: Am J Clin Oncol. 1999 Oct;22(5):436-40
references.pmid: 10521053
references.citation: Nature. 1995 Aug 17;376(6541):596-9
references.pmid: 7637809
references.citation: Carcinogenesis. 2005 Sep;26(9):1527-35
references.pmid: 15878912
references.citation: Genes Chromosomes Cancer. 1998 Mar;21(3):177-84
references.pmid: 9523192
references.citation: Br J Cancer. 2000 Dec;83(12):1688-95
references.pmid: 11104567
references.citation: J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99
references.pmid: 12953083
references.citation: J Biol Chem. 2001 Apr 20;276(16):13153-9
references.pmid: 11278357
references.citation: Cancer Res. 1997 Apr 1;57(7):1222-7
references.pmid: 9102202
references.citation: J Natl Cancer Inst. 2000 Apr 5;92(7):564-9
references.pmid: 10749912
references.citation: Ann Surg. 2001 May;233(5):623-9
references.pmid: 11323500
references.citation: Breast Cancer Res Treat. 1994;32(1):39-47
references.pmid: 7819584
references.citation: Int J Oncol. 2006 Jan;28(1):67-76
references.pmid: 16327981
references.citation: Science. 1993 Feb 12;259(5097):968-71
references.pmid: 8438156
references.citation: Clin Cancer Res. 2007 Jun 1;13(11):3207-14
references.pmid: 17545524
references.citation: J Biol Chem. 1996 Mar 8;271(10):5790-4
references.pmid: 8621447
references.citation: Mol Cell Endocrinol. 2001 Nov 26;184(1-2):135-41
references.pmid: 11694349
references.citation: Oncogene. 2004 Nov 18;23(54):8743-55
references.pmid: 15467738
references.citation: Oncogene. 2000 Jul 13;19(30):3372-83
references.pmid: 10918594
references.citation: Biochim Biophys Acta. 2004 Jun 7;1654(2):105-22
references.pmid: 15172699
references.citation: Lancet. 2005 Feb 19-25;365(9460):671-9
references.pmid: 15721472
references.citation: Int J Cancer. 1998 Aug 12;77(4):522-7
references.pmid: 9679752
references.citation: J Interferon Cytokine Res. 2005 Oct;25(10):587-94
references.pmid: 16241857
references.citation: Cancer Res. 2005 Dec 1;65(23):10692-9
references.pmid: 16322213
references.citation: Cancer Genet Cytogenet. 2007 May;175(1):61-4
references.pmid: 17498560
references.citation: Gastroenterology. 1996 Jan;110(1):52-7
references.pmid: 8536888
references.citation: Carcinogenesis. 2005 Dec;26(12):2031-45
references.pmid: 16150895
references.citation: Cancer Res. 1989 Sep 1;49(17):4682-9
references.pmid: 2547513
references.citation: Neoplasia. 2004 Jan-Feb;6(1):1-6
references.pmid: 15068665
references.citation: Genes Dev. 1999 May 15;13(10):1240-5
references.pmid: 10346812
references.citation: Oncogene. 2004 Feb 5;23(5):1125-35
references.pmid: 14762441
references.citation: Int J Cancer. 2006 Sep 1;119(5):1052-60
references.pmid: 16570289
references.citation: Nature. 1996 Aug 29;382(6594):816-8
references.pmid: 8752276
references.citation: Cancer Res. 2002 Jun 15;62(12):3428-37
references.pmid: 12067985